Abstract :Background and Aim: Intragastric Balloon (IGB) placement is an effective way for weight loss.
However, the impact of IGB on some biomarkers is still unknown. We investigated the impact of
IGB placement on these markers.
Methods: Thirty individuals undergoing IGB and 40 lean controls were enrolled. M30, M65,
adiponectin and thiol- disulfide levels were measured at baseline and at the six months of IGB
placement.
Results: At baseline, patients had significantly higher ALT, M30 and M65 levels compared to the
controls. M30, M65, adiponectin, thiol- disuphide levels and MPV were all found to be similar at the
beginning and end of the IGB therapy.
Conclusion: Our results revealed that IGB placement did not enhance the biomarkers of interest in
the six months of follow up.